Ho, Won Jin
Jaffee, Elizabeth M. http://orcid.org/0000-0003-3841-6549
Zheng, Lei http://orcid.org/0000-0003-4163-2541
Article History
Accepted: 26 March 2020
First Online: 12 May 2020
Competing interests
: W.J.H. could potentially receive patent-related royalties from Rodeo Therapeutics. E.M.J. receives commercial research grants from Aduro Biotech, Amgen, Bristol–Myers Squibb, Corvus and Hertix, has ownership interest in Aduro Biotech, and is a consultant and/or advisory board member for Achilles Therapeutics, Adaptive Biotechnologies, CStone Pharmaceuticals, Dragonfly Therapeutics, Genocea and the Parker Institute for Cancer Immunotherapy. She is a member of the National Cancer Advisory Board and the Chief Medical Advisor for the Lustgarten Foundation. L.Z. receives grant support from Amgen, Bristol–Myers Squibb, Halozyme, Inxmed, iTeos, Merck and NovaRock, and received royalties for licensing GVAX to Aduro Biotech. He is a paid consultant and/or advisory board member for Akrevia, Alphamab, Biosion, Datarevive, Foundation Medicine, Fusun Biopharmaceutical, Mingruzhiyao, NovaRock and Sound Biologics, and holds shares in Alphamab and Mingruzhiyao.